Results 71 to 80 of about 47,892 (267)
PA may delay the onset of age‐related diseases by decelerating biological aging. We found that higher self‐reported amounts of PA in late midlife and device‐based PA in old age were associated with improved MetaboHealth and that reaching twice the amount of the current PA recommendations in late midlife may lead to decelerated biological aging.
Katri Ruutu+5 more
wiley +1 more source
Reprinted Article “The Fate of the Claudicant—A Prospective Study of 1969 Claudicants” [PDF]
A prospective study of 1969 patients with intermittent claudication receiving placebo medication for a minimum of 1 year is reported. Patients were carefully monitored and only four patients were lost to follow-up. Annual mortality was 4.3%. Thirty-six patients developed a definite myocardial infarction, 27 a major stroke, 32 required a major ...
John A. Dormandy, G.D. Murray
openaire +3 more sources
Study Design. Prospective, multicenter, randomized, controlled, investigational device exemption noninferiority trial. Objective. To determine 2-year outcomes in patients with intermittent neurogenic claudication secondary to moderate lumbar spinal ...
V. Patel+8 more
semanticscholar +1 more source
BACKGROUND. Previous studies have shown the positive effect of exercise rehabilitation in patients with claudication, but uncertainties remain surrounding the optimal exercise program strategy and the persistence of the benefits over time. The purpose of
Roberto Carlon+3 more
doaj +1 more source
Intermittent Claudication [PDF]
The diagnosis and therapy of intermittent claudication are critically reviewed. A detailed, concrete and positive program is described whereby every physician can effectively treat patients with intermittent claudication without recourse to intricate diagnostic or therapeutic techniques. The value of this program is illustrated with four case reports.
openaire +2 more sources
Background Previous cross‐sectional studies have identified wide practice pattern variations in the use of peripheral vascular interventions (PVIs) for the treatment of claudication. However, there are limited data on longitudinal practice patterns.
Chen Dun+9 more
doaj +1 more source
Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication
Objectives: To test the effects of pregabalin on the induction of neurogenic claudication. Methods: This study was a randomized, double-blind, active placebo-controlled, 2-period, crossover trial.
J. Markman+9 more
semanticscholar +1 more source
ABSTRACT The risk of atherosclerotic cardiovascular disease increases with advancing age. Elevated LDL‐cholesterol and non‐HDL‐cholesterol levels remain predictive of incident atherosclerotic cardiovascular events among individuals older than 75 years.
Vera Bittner+8 more
wiley +1 more source
The popliteal artery adventitial cyst is not a commonly studied pathology due to the rarity of its occurrence, however it is a disease that should always be considered as a differential diagnosis in the presence of a young patient who complains of ...
Angelo Frankini+2 more
doaj
There are limited data on the comparative effectiveness of medical therapy, supervised exercise, and revascularization to improve walking and quality of life in patients with intermittent claudication (IC).
S. Vemulapalli+7 more
semanticscholar +1 more source